Dexcom Announces Upcoming Conference Presentation
Dexcom (NASDAQ: DXCM) has announced that its top executives will present at the 2024 Wells Fargo Healthcare Conference on September 4th. Kevin Sayer, Chairman, President and CEO, along with Jereme Sylvain, Executive VP and CFO, will provide an update on the company. The presentation is scheduled for 11:00 AM EST and will be webcast live.
Investors and interested parties can access the webcast through the Dexcom Investor Relations website at investors.dexcom.com. The presentation will also be archived on the site for future reference, allowing those unable to attend the live event to catch up later.
Dexcom (NASDAQ: DXCM) ha annunciato che i suoi principali dirigenti presenteranno alla Conferenza Sanitaria Wells Fargo 2024 il 4 settembre. Kevin Sayer, Presidente e CEO, insieme a Jereme Sylvain, Vice Presidente Esecutivo e CFO, forniranno un aggiornamento sull'azienda. La presentazione è programmata per le 11:00 AM EST e sarà trasmessa in diretta.
Gli investitori e le parti interessate possono accedere alla trasmissione tramite il sito web delle Relazioni con gli Investitori Dexcom all'indirizzo investors.dexcom.com. La presentazione sarà inoltre archiviata sul sito per future consultazioni, consentendo a chi non può partecipare all'evento dal vivo di recuperare successivamente.
Dexcom (NASDAQ: DXCM) ha anunciado que sus altos ejecutivos presentarán en la Conferencia de Salud de Wells Fargo 2024 el 4 de septiembre. Kevin Sayer, Presidente y CEO, junto con Jereme Sylvain, Vicepresidente Ejecutivo y CFO, proporcionarán una actualización sobre la compañía. La presentación está programada para las 11:00 AM EST y será transmitida en vivo.
Los inversores y partes interesadas pueden acceder a la transmisión a través del sitio web de Relaciones con Inversores de Dexcom en investors.dexcom.com. La presentación también estará archivada en el sitio para referencia futura, permitiendo a aquellos que no puedan asistir al evento en vivo ponerse al día más tarde.
Dexcom (NASDAQ: DXCM)는 주요 임원들이 9월 4일 2024 웰스 파고 헬스케어 컨퍼런스에서 발표할 것이라고 발표했습니다. Kevin Sayer 의장, 사장 겸 CEO와 Jereme Sylvain 부사장 겸 CFO가 회사에 대한 업데이트를 제공합니다. 발표는 동부 표준시로 오전 11시 00분에 예정되어 있으며 실시간 방송될 것입니다.
투자자와 이해관계자는 Dexcom 투자자 관계 웹사이트인 investors.dexcom.com을 통해 방송에 접속할 수 있습니다. 발표는 나중에 참석할 수 없는 사람들도 다시 볼 수 있도록 사이트에 저장될 예정입니다.
Dexcom (NASDAQ: DXCM) a annoncé que ses principaux dirigeants présenteront lors de la Conférence Santé Wells Fargo 2024 le 4 septembre. Kevin Sayer, Président et CEO, ainsi que Jereme Sylvain, Vice-Président Exécutif et CFO, fourniront une mise à jour sur l'entreprise. La présentation est prévue à 11h00 EST et sera diffusée en direct.
Les investisseurs et les parties intéressées peuvent accéder à la diffusion via le site Web des Relations Investisseurs de Dexcom à l'adresse investors.dexcom.com. La présentation sera également archivée sur le site pour une référence future, permettant à ceux qui ne peuvent assister à l'événement en direct de se rattraper plus tard.
Dexcom (NASDAQ: DXCM) hat angekündigt, dass seine Führungskräfte am 4. September auf der Wells Fargo Healthcare Conference 2024 präsentieren werden. Kevin Sayer, Vorsitzender, Präsident und CEO, zusammen mit Jereme Sylvain, Executive VP und CFO, werden eine Aktualisierung über das Unternehmen geben. Die Präsentation ist für 11:00 Uhr EST angesetzt und wird live übertragen.
Investoren und Interessierte können über die Dexcom Investor Relations-Website auf den Livestream zugreifen unter investors.dexcom.com. Die Präsentation wird zudem auf der Seite archiviert werden, sodass auch diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, später nachholen können.
- None.
- None.
The live presentation is scheduled to begin at approximately 11:00 AM EST and will be concurrently webcast.
Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring systems. Headquartered in
Category: IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828543534/en/
DexCom, Inc.
Sean Christensen
Vice President – Finance and Investor Relations
investor-relations@dexcom.com
(858) 200-0200
Source: DexCom, Inc.
FAQ
When is Dexcom (DXCM) presenting at the 2024 Wells Fargo Healthcare Conference?
Who will be presenting for Dexcom (DXCM) at the Wells Fargo Healthcare Conference?
How can I watch Dexcom's (DXCM) presentation at the Wells Fargo Healthcare Conference?
Will Dexcom's (DXCM) presentation at the Wells Fargo Healthcare Conference be available after the event?
